ProteinInsight AI
Sign in
Structure-based drug discovery, end to end

Turn protein structure into faster discovery decisions.

Structure, docking, ADMET, PK/PD and safety in one research-grade workspace — taking your team from raw sequence to sourced evidence in minutes, not weeks.

Research use only. No sign-up required to explore the demo.

Three-dimensional protein structure with a ligand bound inside its binding pocket
DOCKING SCORE
−9.4kcal/mol
PK EXPOSURE

Wired into the data sources scientists already trust

UniProtRCSB PDBAlphaFoldESM AtlasChEMBLopenFDA
12
Drug-development stages unified — target discovery to post-market
6+
Public data sources, synced on demand and cited in every result
4
Candidate modalities: small molecule, antibody, peptide and RNA
100%
Research-use-only, with reproducible and fully sourced evidence
Live demo · no sign-up

Explore a real blood-cancer pipeline, instantly

Loading the demo programs…

Explore opens a read-only demo. Create editable sandbox spins up a private, throwaway copy you can edit and run analyses in (auto-expires in 24h). Research use only — not for clinical decision-making.

From sequence to sourced report in three steps

No installs, no pipelines to wire up. Load a target and start discovering.

1

Import your target & protein

Load a protein by UniProt ID, AlphaFold ID, or FASTA sequence and inspect it in 3D instantly.

2

Run the analyses

Docking, ADMET, PK/PD, response simulation and safety signals — run them side by side and rank candidates with calibrated confidence.

3

Generate an evidence report

Produce a restrained, research-use AI report with sources, assumptions and limitations, and share it with your team.

One workspace for every structure-based workflow

WebGL protein viewer
WebGL protein viewer→

Rotate and zoom the 3D structure; colour by chain, ligand, binding pocket or pLDDT confidence, and hand a residue straight to docking.

Ligand docking lab
Ligand docking lab→

Configure grid boxes and parameters, dock ligand poses, and review interaction maps ranked by binding score and confidence.

ADMET risk analysis
ADMET risk analysis→

Estimate absorption, metabolism, toxicity and drug-likeness risk as low / medium / high signals, with rule-based evidence (Lipinski, PAINS…).

PK/PD simulation
PK/PD simulation→

Simulate concentration–time curves and compute exposure metrics (AUC, Cmax) to compare dosing scenarios.

Response simulation
Response simulation→

Simulate computational response possibility across virtual cohorts with Emax/Hill models to explore a candidate’s response profile.

Safety signal review
Safety signal review→

Aggregate openFDA FAERS adverse-event data to review safety signals for research interpretation.

Purpose-built for the entire drug-development journey

Target discovery to post-market — twelve stages in one coherent workspace, not generic project tooling.

01Disease & Target02Candidate Discovery03Optimization04Preclinical05IND06Phase 107Phase 208Phase 309NDA / BLA10CMC / GMP11Launch12Post-market

Protein structure viewer

Inspect chains, ligands, pockets and domains in a dark WebGL workspace; send a residue straight to a docking grid.

Ligand docking lab

Configure grid boxes and parameters, rank poses, and review interaction maps with confidence scoring.

ADMET & safety risk

Estimate absorption, metabolism, toxicity and drug-likeness risk with calibrated low / medium / high signals.

PK/PD response simulation

Simulate concentration–time curves and computational response possibility across virtual cohorts.

AI research report

Generate evidence-backed, restrained research reports with sources, assumptions and limitations.

Connected data sources

UniProtKB, RCSB PDB, AlphaFold, ESM Atlas and Biohub Fold — synced on demand, cached selectively.

Trust isn't a feature — it's the foundation

Rigor, reproducibility and isolation come as standard.

Research use only

Every prediction-bearing screen carries the research-use disclaimer — never for clinical diagnosis, prescription, or treatment.

Reproducible evidence

Every result is tagged with its source, computation type and confidence, so findings can be verified — not taken on faith.

Multi-tenant isolation

Data is scoped per organization with role-based access control and audit logging on sensitive actions.

Your next discovery starts here

Jump into the live demo instantly — no sign-up — or spin up your own workspace and run real analyses in minutes.